AstraZeneca PLC (AZN) vs Invesco QQQ Trust, Series 1 (QQQ)
Over the past 10 years, AZN lagged QQQ — 13.96% vs 20.13% annualized total return (price plus dividends).
A side-by-side comparison of AstraZeneca PLC and Invesco QQQ Trust, Series 1 across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Total return — AZN vs QQQ
growth of $100 · dividends reinvested · last 27yMetrics side by side
Did AZN beat QQQ?
Over the past 10 years, AZN lagged QQQ — 13.96% vs 20.13% annualized total return (price plus dividends).
Total return (annualized)
| Metric | AZN | QQQ |
|---|---|---|
| Total return (1Y) | 18.74% | 18.63% |
| Total return CAGR (3Y) | 8.68% | 21.17% |
| Total return CAGR (5Y) | 10.56% | 13.57% |
| Total return CAGR (10Y) | 13.96% | 20.13% |
QQQ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has AZN beaten QQQ?
- Over the past 10 years, AZN lagged QQQ — 13.96% vs 20.13% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.